Clinical Grade Non-Transfusable Mobilized Peripheral Blood CD34+ Stem Cells, G-CSF + Plerixafor, Frozen | StemExpress

Clinical Grade Non-Transfusable Mobilized Peripheral Blood CD34+ Stem Cells, G-CSF + Plerixafor, Frozen

$0
In stock
SKU
Category: Clinical Products
Select SKU Size / Day Price
cMLEGP34001C 1 million/vial Inquire
cMLEGP34005C 5 million/vial Inquire
cMLEGP34000.2C 0.2 million/vial Inquire
cMLEGP34010C 10 million/vial Inquire
cMLEGP34020C 20 million/vial Inquire
-
+
Questions about shipping? See Shipping Info
Questions? Contact Sales:
530-303-3828
Contact Us
Product Description

CD34 is a glycosylated transmembrane protein and represents a well-established marker for human hematopoietic stem and progenitor cells in peripheral blood, bone marrow, cord blood, and fetal liver. CD34+ cells are self-renewing, multipotent stem cells that give rise to all blood cells of the immune system through a process called hematopoiesis. As hematopoietic stem cells progress through hematopoiesis they generate the myeloid (monocytes, macrophages, granulocytes, megakaryocytes, dendritic cells, and erythrocytes), and lymphoid (T cells, B cells, and NK cells) lineages. The highly specialized cells that arise from hematopoietic stem cells work collaboratively in defending the body against infection and disease.

Human mobilized peripheral blood CD34+ cells are enriched from the total cell population using direct immunomagnetic anti-CD34 beads. All cell isolation components, including reagents, tubing sets, instruments, and buffers, are manufactured and controlled under an ISO 13485 certified quality system under FDA oversight. Cell culture procedures, including open manipulation of vials, final filling, and closure of finished products, are performed inside ISO 5 air quality processing chambers located within an FDA-registered cell manufacturing facility. Isolated primary cells are characterized by flow cytometry to ensure a highly pure and viable cell population.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols. All reagents and devices used to collect and separate the cells are certified clinical grade. This item is for research use only.

More Information
Species Human
Disease State Healthy
Cell and Tissue Source Peripheral Blood
Product Type Primary Cells
Cell Type Stem/Progenitor Cells
Donor Attributes HIV-, HepB-, HepC-
Purity ≥85% by Flow Cytometry
Viability ≥80% by Flow Cytometry
Format Frozen
Contains StemSpan™ and 10% DMSO
Anticoagulant ACD-A
Injections 10μg/kg/day of G-CSF & 240μg/kg Plerixafor the day before collection

Hi, have questions?

A StemExpress Expert is happy to help!

Call 530.303.3828 or Contact Us